| Year |
Citation |
Score |
| 2024 |
Huntington SF, Manzoor BS, Jawaid D, Puckett JT, Emechebe N, Ravelo A, Kamal-Bahl S, Doshi JA. Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton's tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting. Journal of Managed Care & Specialty Pharmacy. 1-11. PMID 39046941 DOI: 10.18553/jmcp.2024.24049 |
0.653 |
|
| 2024 |
Squires P, Puckett J, Ryland KE, Kamal-Bahl S, Raut M, Doshi J, Huntington SF. Real-World Treatment Patterns, Survival, and Economic Burden Among Elderly MCL Patients Previously Treated With cBTKis. Clinical Lymphoma, Myeloma & Leukemia. PMID 39034204 DOI: 10.1016/j.clml.2024.05.023 |
0.759 |
|
| 2024 |
Garg M, Puckett J, Kamal-Bahl S, Raut M, Ryland KE, Doshi JA, Huntington SF. Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting. Clinical Lymphoma, Myeloma & Leukemia. PMID 38433043 DOI: 10.1016/j.clml.2024.01.010 |
0.752 |
|
| 2024 |
Huntington SF, de Nigris E, Puckett JT, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong EM, Leng S, Yang X, Doshi JA. Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia. Cancer Medicine. 13: e6953. PMID 38348963 DOI: 10.1002/cam4.6953 |
0.656 |
|
| 2023 |
Garg M, Puckett J, Kamal-Bahl S, Raut M, Ryland KE, Doshi JA, Huntington SF. Real-world treatment patterns, survival, health resource use and costs among Medicare beneficiaries with diffuse large B-cell lymphoma. Future Oncology (London, England). PMID 38050764 DOI: 10.2217/fon-2023-0191 |
0.764 |
|
| 2023 |
Huntington SF, de Nigris E, Puckett J, Kamal-Bahl S, Farooqui M, Ryland K, Sarpong E, Leng S, Yang X, Doshi JA. Ibrutinib discontinuation and associated factors in a real-world national sample of elderly Medicare beneficiaries with chronic lymphocytic leukemia. Leukemia & Lymphoma. 1-10. PMID 37870435 DOI: 10.1080/10428194.2023.2256911 |
0.687 |
|
| 2023 |
Huntington SF, Manzoor BS, Puckett JT, Kamal-Bahl S, Alhasani H, Ravelo A, Jawaid D, Doshi JA. Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia. Leukemia & Lymphoma. 1-8. PMID 37732602 DOI: 10.1080/10428194.2023.2255326 |
0.68 |
|
| 2023 |
Squires P, Puckett J, Ryland KE, Kamal-Bahl S, Raut M, Doshi JA, Huntington SF. Assessing unmet need among elderly Medicare Beneficiaries with Mantle cell lymphoma: an analysis of treatment patterns, survival, healthcare resource utilization, and costs. Leukemia & Lymphoma. 64: 1752-1770. PMID 37497877 DOI: 10.1080/10428194.2023.2234525 |
0.763 |
|
| 2022 |
Dubberke ER, Puckett JT, Obi EN, Kamal-Bahl S, Desai K, Stuart B, Doshi JA. Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Infection and Associated Clinical Outcomes. Open Forum Infectious Diseases. 9: ofac435. PMID 36267250 DOI: 10.1093/ofid/ofac435 |
0.702 |
|
| 2022 |
Stuart B, Loh FE, Kamal-Bahl S, Vietri J, Bakken D, Puckett J, Doshi JA. Financial incentives tied to Medicare star ratings: impact on influenza vaccination uptake in Medicare beneficiaries. The American Journal of Managed Care. 28: 273-280. PMID 35738223 DOI: 10.37765/ajmc.2022.89154 |
0.682 |
|
| 2020 |
Taylor DCA, Abel JL, Martin C, Doshi JA, Essoi B, Korrer S, Reasner DS, Carson RT, Goolsby Hunter A. Comprehensive assessment of patients with irritable bowel syndrome with constipation and chronic idiopathic constipation using deterministically linked administrative claims and patient-reported data: The Chronic Constipation and IBS-C Treatment and Outcomes Real-world Research Platform (CONTOR). Journal of Medical Economics. 1. PMID 32696684 DOI: 10.1080/13696998.2020.1799816 |
0.355 |
|
| 2020 |
Marcus SC, Shewale AR, Silberstein SD, Lipton RB, Young WB, Viswanathan HN, Doshi JA. Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response. Cephalalgia : An International Journal of Headache. 333102420915167. PMID 32223301 DOI: 10.1177/0333102420915167 |
0.336 |
|
| 2020 |
Lipton RB, Marcus SC, Shewale AR, Dodick DW, Viswanathan HN, Doshi JA. Acute treatment patterns in patients with migraine newly initiating a triptan. Cephalalgia : An International Journal of Headache. 333102420905307. PMID 32138526 DOI: 10.1177/0333102420905307 |
0.33 |
|
| 2020 |
Doshi JA, Li P, Puckett JT, Pettit AR, Raman S, Parmacek MS, Rader DJ. Trends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Prescriptions. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 23: 209-216. PMID 32113626 DOI: 10.1016/J.Jval.2019.08.011 |
0.306 |
|
| 2020 |
Doshi JA, Li P, Puckett J, Pettit A, Parmacek MS, Rader D. Abstract 285: Association Of Patient Out-of-pocket Costs And Financial Assistance With Prescription Abandonment: The Case Of PCSK9 Inhibitors Circulation: Cardiovascular Quality and Outcomes. 13. DOI: 10.1161/Hcq.13.Suppl_1.285 |
0.364 |
|
| 2019 |
Pilon D, El Khoury AC, Manceur AM, Zhdanava M, Benson C, Lefebvre P, Doshi JA. Are Medicaid Coverage Gaps Associated with Higher Health Care Resource Utilization and Costs in Patients with Schizophrenia? Population Health Management. PMID 31592717 DOI: 10.1089/Pop.2019.0147 |
0.344 |
|
| 2019 |
Taylor DCA, Abel JL, Doshi JA, Martin C, Goolsby Hunter A, Essoi B, Korrer S, Reasner DS, Carson RT, Chey WD. The Impact of Stool Consistency on Bowel Movement Satisfaction in Patients With IBS-C or CIC Treated With Linaclotide or Other Medications: Real-World Evidence From the CONTOR Study. Journal of Clinical Gastroenterology. PMID 31361710 DOI: 10.1097/Mcg.0000000000001245 |
0.303 |
|
| 2019 |
Abel JL, Burslem K, Doshi JA, Lee L. Sa1033 – Healthcare Resource Use and Direct Medical Costs Associated with Diabetic Gastroparesis Gastroenterology. 156: S-262. DOI: 10.1016/S0016-5085(19)37460-8 |
0.321 |
|
| 2018 |
Mato A, Jahnke J, Li P, Mehra M, Ladage VP, Mahler M, Huntington S, Doshi JA. Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era. Haematologica. PMID 29700170 DOI: 10.3324/Haematol.2017.185868 |
0.312 |
|
| 2018 |
Garrison LP, Neumann PJ, Willke RJ, Basu A, Danzon PM, Doshi JA, Drummond MF, Lakdawalla DN, Pauly MV, Phelps CE, Ramsey SD, Towse A, Weinstein MC. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 21: 161-165. PMID 29477394 DOI: 10.1016/J.Jval.2017.12.009 |
0.305 |
|
| 2018 |
Doshi JA, Puckett JT, Parmacek MS, Rader DJ. Prior Authorization Requirements for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Across US Private and Public Payers. Circulation. Cardiovascular Quality and Outcomes. 11: e003939. PMID 29326146 DOI: 10.1161/Circoutcomes.117.003939 |
0.305 |
|
| 2018 |
Li P, Glick H, Puckett J, Jahnke J, Takeshita J, Gelfand J, Li N, Villacorta R, McElligott S, Doshi J. Health Care Costs Associated with Different Biologic Treatment Patterns Among U.S. Medicare Patients with Psoriasis Value in Health. 21: S263-S264. DOI: 10.1016/J.Jval.2018.04.1760 |
0.345 |
|
| 2018 |
Marcus S, Shewale A, Doshi J, Young W, Yu J, Pavlovic J, Viswanathan H. Economic Burden of Diagnosed Chronic Migraine and Diagnosed Episodic Migraine Patients in a Large US Health Insurer’s Population Value in Health. 21: S209. DOI: 10.1016/J.Jval.2018.04.1417 |
0.31 |
|
| 2017 |
Doshi JA, Li P, Huo H, Pettit AR, Armstrong KA. Association of Patient Out-of-Pocket Costs With Prescription Abandonment and Delay in Fills of Novel Oral Anticancer Agents. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017745091. PMID 29261440 DOI: 10.1200/Jco.2017.74.5091 |
0.344 |
|
| 2017 |
Li P, Wong YN, Jahnke J, Pettit AR, Doshi JA. Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma. Cancer Medicine. PMID 29195016 DOI: 10.1002/Cam4.1262 |
0.39 |
|
| 2017 |
Doshi JA, Li P, Desai S, Marcus SC. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia. Journal of Medical Economics. 1-19. PMID 28792299 DOI: 10.1080/13696998.2017.1365720 |
0.303 |
|
| 2017 |
Li P, Hu T, Yu X, Chahin S, Dahodwala N, Blum M, Pettit AR, Doshi JA. Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study. Health Services Research. PMID 28736929 DOI: 10.1111/1475-6773.12744 |
0.327 |
|
| 2017 |
Taylor DC, Abel JL, Doshi JA, Martin C, Hunter AG, Essoi B, Korrer S, Carson RT, Reasner DS, Chey WD. Impact of Stool Consistency on Bowel Movement Satisfaction in IBS-C or CIC Patients Treated With Linaclotide or Other Medications: Results From the CONTOR Study American Journal of Gastroenterology. 112: S228. DOI: 10.14309/00000434-201710001-00425 |
0.308 |
|
| 2016 |
Li P, Schwartz JS, Doshi JA. Impact of Cost Sharing on Therapeutic Substitution: The Story of Statins in 2006. Journal of the American Heart Association. 5. PMID 27836822 DOI: 10.1161/Jaha.116.003377 |
0.353 |
|
| 2016 |
Doshi JA, Lim R, Li P, Young PP, Lawnicki VF, State JJ, Troxel AB, Volpp KG. A Synchronized Prescription Refill Program Improved Medication Adherence. Health Affairs (Project Hope). 35: 1504-12. PMID 27503977 DOI: 10.1377/Hlthaff.2015.1456 |
0.332 |
|
| 2016 |
Li P, Doshi JA. Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012. Plos One. 11: e0154357. PMID 27149092 DOI: 10.1371/Journal.Pone.0154357 |
0.301 |
|
| 2016 |
Doshi JA, Hendrick FB, Graff JS, Stuart BC. Data, Data Everywhere, but Access Remains a Big Issue for Researchers: A Review of Access Policies for Publicly-Funded Patient-Level Health Care Data in the United States. Egems (Washington, Dc). 4: 1204. PMID 27141517 DOI: 10.13063/2327-9214.1204 |
0.483 |
|
| 2016 |
Doshi JA, Li P, Ladage VP, Pettit AR, Taylor EA. Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions. The American Journal of Managed Care. 22: 188-197. PMID 27023024 DOI: 10.1016/J.Jval.2015.03.468 |
0.379 |
|
| 2016 |
Doshi JA, Hu T, Li P, Pettit AR, Yu X, Blum M. Specialty Tier-Level Cost Sharing and Biologic Use in the Medicare Part D Initial Coverage Period among Beneficiaries with Rheumatoid Arthritis. Arthritis Care & Research. PMID 27014854 DOI: 10.1002/Acr.22880 |
0.314 |
|
| 2016 |
Doshi JA, Takeshita J, Pinto L, Li P, Yu X, Rao P, Viswanathan HN, Gelfand JM. Biologic therapy adherence, discontinuation, switching, and restarting among patients with psoriasis in the US Medicare population. Journal of the American Academy of Dermatology. PMID 26946986 DOI: 10.1016/J.Jaad.2016.01.048 |
0.309 |
|
| 2016 |
Li P, Wong Y, Jahnke J, Doshi JA. Association of high cost sharing and target therapy initiation among Medicare patients with metastatic renal cell carcinoma. Journal of Clinical Oncology. 34: 4562-4562. DOI: 10.1200/Jco.2016.34.15_Suppl.4562 |
0.309 |
|
| 2016 |
Mato AR, Jahnke J, Li P, Mehra M, Ladage VP, Mahler M, Fanning M, Doshi JA, Huntington SF. Characterization of Real World Survival Outcomes Among Older Adults with Chronic Lymphocytic Leukemia Receiving Second Line Treatment in the Pre Novel-Agents Era: An Analysis of the 2007-2013 SEER-Medicare Database Blood. 128: 4790-4790. DOI: 10.1182/Blood.V128.22.4790.4790 |
0.368 |
|
| 2016 |
Mato AR, Jahnke J, Li P, Mehra M, Ladage VP, Mahler M, Huntington SF, Doshi JA. Characterization of Real World Treatment Patterns and Outcomes Among Older Adults with Chronic Lymphocytic Leukemia in the Pre Novel-Agents Era: An Analysis of the 2007-2013 SEER-Medicare Database Blood. 128: 4773-4773. DOI: 10.1182/Blood.V128.22.4773.4773 |
0.376 |
|
| 2016 |
Doshi J, Li P, Pettit A, Dougherty J. MEDICARE PART D OUT-OF-POCKET COST PATTERNS FOR SPECIALTY DRUG USERS DURING THE CALENDAR YEAR: TOO MUCH TOO SOON Value in Health. 19: A261. DOI: 10.1016/J.Jval.2016.03.794 |
0.313 |
|
| 2016 |
Doshi J, Li P, Huo H, Pettit A, Kumar R, Huntington S, Weiss B. Medicare Part D Cost Sharing And Specialty Drug Initiation In Newly Diagnosed Chronic Myeloid Leukemia Patients Value in Health. 19: A3. DOI: 10.1016/J.Jval.2016.03.035 |
0.369 |
|
| 2015 |
Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. The Lancet. Haematology. 2: e408-16. PMID 26686042 DOI: 10.1016/S2352-3026(15)00151-9 |
0.348 |
|
| 2015 |
Marcus SC, Zummo J, Pettit AR, Stoddard J, Doshi JA. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge. Journal of Managed Care & Specialty Pharmacy. 21: 754-68. PMID 26308223 DOI: 10.18553/Jmcp.2015.21.9.754 |
0.328 |
|
| 2015 |
Takeshita J, Gelfand JM, Li P, Pinto L, Yu X, Rao P, Viswanathan HN, Doshi JA. Psoriasis in the U.S. Medicare Population: Prevalence, Treatment, and Factors Associated with Biologic Use. The Journal of Investigative Dermatology. PMID 26214380 DOI: 10.1038/Jid.2015.296 |
0.332 |
|
| 2015 |
Doshi JA, Pettit AR, Stoddard JJ, Zummo J, Marcus SC. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge. Journal of Clinical Psychopharmacology. 35: 442-446. PMID 26075492 DOI: 10.1097/Jcp.0000000000000353 |
0.351 |
|
| 2015 |
Glick HA, McElligott S, Pauly MV, Willke RJ, Bergquist H, Doshi J, Fleisher LA, Kinosian B, Perfetto E, Polsky DE, Schwartz JS. Comparative effectiveness and cost-effectiveness analyses frequently agree on value. Health Affairs (Project Hope). 34: 805-11. PMID 25941282 DOI: 10.1377/Hlthaff.2014.0552 |
0.357 |
|
| 2015 |
Huntington SF, Svoboda J, Doshi JA. Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1467-74. PMID 25823735 DOI: 10.1200/Jco.2014.58.5729 |
0.305 |
|
| 2015 |
Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Doshi JA, Stadtmauer EA. Assessing financial toxicity in insured patients with multiple myeloma. Journal of Clinical Oncology. 33: 6600-6600. DOI: 10.1200/Jco.2015.33.15_Suppl.6600 |
0.322 |
|
| 2015 |
Li P, Schwartz S, Doshi J. Influence Of Cost Sharing Differentials On Therapeutic Substitution And Medication Adherence: The Story Of Statins In 2006 Value in Health. 18: A147-A148. DOI: 10.1016/J.Jval.2015.03.859 |
0.333 |
|
| 2015 |
Li P, Hu T, Yu X, Chahin S, Dahodwala N, Doshi J. Impact of cost sharing increases under part D specialty tiers on Biologic adherence and discontinuation among Medicare Beneficiaries with multiple Sclerosis or Rheumatoid Arthritis Value in Health. 18: A79-A80. DOI: 10.1016/J.Jval.2015.03.465 |
0.302 |
|
| 2015 |
Doshi J, Li P, Yu X, Dahodwala N, Chahin S. Specialty tier cost sharing and use of disease modifying Therapies Among Medicare Beneficiaries with Multiple Sclerosis Value in Health. 18: A289. DOI: 10.1016/J.Jval.2015.03.1687 |
0.306 |
|
| 2014 |
Li P, Metlay JP, Marcus SC, Doshi JA. Factors associated with antimicrobial drug use in medicaid programs. Emerging Infectious Diseases. 20: 829-32. PMID 24751202 DOI: 10.3201/Eid2005.130493 |
0.327 |
|
| 2014 |
Doshi JA, Cai Q, Buono JL, Spalding WM, Sarocco P, Tan H, Stephenson JJ, Carson RT. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population. Journal of Managed Care & Specialty Pharmacy. 20: 382-90. PMID 24684643 DOI: 10.18553/Jmcp.2014.20.4.382 |
0.303 |
|
| 2014 |
Cai Q, Buono JL, Spalding WM, Sarocco P, Tan H, Stephenson JJ, Carson RT, Doshi JA. Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population. Journal of Medical Economics. 17: 148-58. PMID 24168640 DOI: 10.3111/13696998.2013.860375 |
0.355 |
|
| 2014 |
Doshi J, Li P, Hu T, Subedi P, Davis-Cerone M. Cost-Sharing And Use Of Biologic Therapies In Medicare Patients With Rheumatoid Arthritis Value in Health. 17: A54. DOI: 10.1016/J.Jval.2014.03.319 |
0.328 |
|
| 2013 |
Cai Q, Spalding W, Buono J, Stephenson J, Tan H, Sarocco P, Carson R, Doshi J. Economic Burden Of Chronic Constipation Among Patients In A Commercially Insured Population: A Retrospective Analysis Of All-Cause Costs Value in Health. 16: A213. DOI: 10.1016/J.Jval.2013.03.1079 |
0.342 |
|
| 2012 |
Stuart B, Yin X, Davidoff A, Simoni-Wastila L, Zuckerman I, Shoemaker JS, Doshi J. Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes. Medical Care. 50: 913-9. PMID 23047779 DOI: 10.1097/Mlr.0B013E31826C85F9 |
0.549 |
|
| 2012 |
Decker SL, Doshi JA, Knaup AE, Polsky D. Health service use among the previously uninsured: is subsidized health insurance enough? Health Economics. 21: 1155-68. PMID 22945812 DOI: 10.1002/Hec.1780 |
0.311 |
|
| 2012 |
Kimmel SE, Troxel AB, Loewenstein G, Brensinger CM, Jaskowiak J, Doshi JA, Laskin M, Volpp K. Randomized trial of lottery-based incentives to improve warfarin adherence. American Heart Journal. 164: 268-74. PMID 22877814 DOI: 10.1016/J.Ahj.2012.05.005 |
0.305 |
|
| 2012 |
Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Annals of Internal Medicine. 156: 776-84, W-263, W-264. PMID 22665815 DOI: 10.7326/0003-4819-156-11-201206050-00004 |
0.303 |
|
| 2011 |
Stuart B, Simoni-Wastila L, Yin X, Davidoff A, Zuckerman IH, Doshi J. Medication use and adherence among elderly Medicare beneficiaries with diabetes enrolled in Part D and retiree health plans. Medical Care. 49: 511-5. PMID 21422956 DOI: 10.1097/Mlr.0B013E31820Bf885 |
0.577 |
|
| 2010 |
Shaffer T, Simoni-Wastila L, Toler W, Stuart B, Doshi JA. Changing patterns in medication use with increasing probability of death for older Medicare beneficiaries. Journal of the American Geriatrics Society. 58: 1549-55. PMID 20670381 DOI: 10.1111/J.1532-5415.2010.02957.X |
0.557 |
|
| 2010 |
Kim MM, Metlay J, Cohen A, Feldman H, Hennessy S, Kimmel S, Strom B, Doshi JA. Hospitalization costs associated with warfarin-related bleeding events among older community-dwelling adults. Pharmacoepidemiology and Drug Safety. 19: 731-6. PMID 20583203 DOI: 10.1002/Pds.1953 |
0.349 |
|
| 2010 |
Gibson T, Jing Y, Bagalman E, Cao Z, Bates J, Hebden T, Forbes R, Doshi J. Me3 Impact Of Cost Sharing On Treatment Augmentation In Patients With Depression Value in Health. 13. DOI: 10.1016/S1098-3015(10)72015-5 |
0.313 |
|
| 2009 |
Stuart BC, Simoni-Wastila L, Zhao L, Lloyd JT, Doshi JA. Increased persistency in medication use by U.S. Medicare beneficiaries with diabetes is associated with lower hospitalization rates and cost savings. Diabetes Care. 32: 647-9. PMID 19171724 DOI: 10.2337/Dc08-1311 |
0.551 |
|
| 2009 |
Doshi JA, Zhu J, Lee BY, Kimmel SE, Volpp KG. Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. Circulation. 119: 390-7. PMID 19139387 DOI: 10.1161/Circulationaha.108.783944 |
0.313 |
|
| 2009 |
Stuart BC, Doshi JA, Terza JV. Assessing the impact of drug use on hospital costs. Health Services Research. 44: 128-44. PMID 18783453 DOI: 10.1111/J.1475-6773.2008.00897.X |
0.567 |
|
| 2008 |
Rosenheck RA, Leslie DL, Doshi JA. Second-generation antipsychotics: cost-effectiveness, policy options, and political decision making. Psychiatric Services (Washington, D.C.). 59: 515-20. PMID 18451007 DOI: 10.1176/Appi.Ps.59.5.515 |
0.365 |
|
| 2008 |
Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics. 121: e441-8. PMID 18310165 DOI: 10.1542/Peds.2007-0984 |
0.324 |
|
| 2007 |
Stuart BC, Briesacher BA, Doshi JA, Wrobel MV, Baysac F. Will part D produce savings in part A and part B? The impact of prescription drug coverage on medicare program expenditures Inquiry. 44: 146-156. DOI: 10.5034/Inquiryjrnl_44.2.146 |
0.58 |
|
| 2006 |
Polsky D, Doshi JA, Bauer MS, Glick HA. Clinical trial-based cost-effectiveness analyses of antipsychotic use. The American Journal of Psychiatry. 163: 2047-56. PMID 17151153 DOI: 10.1176/Appi.Ajp.163.12.2047 |
0.327 |
|
| 2006 |
Doshi JA, Glick HA, Polsky D. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 9: 334-40. PMID 16961551 DOI: 10.1111/J.1524-4733.2006.00122.X |
0.313 |
|
| 2005 |
Briesacher BA, Stuart B, Ren X, Doshi JA, Wrobel MV. Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending. Health Services Research. 40: 1279-96. PMID 16174134 DOI: 10.1111/J.1475-6773.2005.00432.X |
0.571 |
|
| 2005 |
Briesacher BA, Limcangco MR, Simoni-Wastila L, Doshi JA, Levens SR, Shea DG, Stuart B. The quality of antipsychotic drug prescribing in nursing homes. Archives of Internal Medicine. 165: 1280-5. PMID 15956008 DOI: 10.1001/Archinte.165.11.1280 |
0.517 |
|
| 2005 |
Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 medicare current beneficiary survey and the 1996 medical expenditure survey. Journal of the American Geriatrics Society. 53: 438-43. PMID 15743286 DOI: 10.1111/J.1532-5415.2005.53161.X |
0.304 |
|
| 2004 |
Stuart B, Doshi JA, Briesacher B, Wrobel MV, Baysac F. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease. Clinical Therapeutics. 26: 1688-99. PMID 15598486 DOI: 10.1016/J.Clinthera.2004.10.012 |
0.567 |
|
| 2004 |
Stuart B, Singhal PK, Fahlman C, Doshi J, Briesacher B. Employer-sponsored health insurance and prescription drug coverage for new retirees: dramatic declines in five years. Health Affairs (Project Hope). W3-334-41. PMID 15506136 DOI: 10.1377/Hlthaff.W3.334 |
0.557 |
|
| 2004 |
Doshi JA, Brandt N, Stuart B. The impact of drug coverage on COX-2 inhibitor use in Medicare. Health Affairs (Project Hope). W4-94-105. PMID 15451967 DOI: 10.1377/Hlthaff.W4.94 |
0.569 |
|
| 2004 |
Morton AH, Goldstein DJ, Kamal-Bahl SJ, Doshi JA, Stuart BC, Briesacher BA. Inappropriately defining "inappropriate medication for the elderly" [1] (multiple letters) Journal of the American Geriatrics Society. 52: 1580-1582. PMID 15341569 |
0.706 |
|
| 2004 |
Kamal-Bahl SJ, Doshi JA, Stuart BC, Briesacher BA. RESPONSE LETTER TO DRS. MORTON AND GOLDSTEIN Journal of the American Geriatrics Society. 52: 1581-1582. DOI: 10.1111/J.1532-5415.2004.52430_3.X |
0.468 |
|
| 2003 |
Stuart B, Kamal-Bahl S, Briesacher B, Lee E, Doshi J, Zuckerman IH, Verovsky I, Beers MH, Erwin G, Friedley N. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. The American Journal of Geriatric Pharmacotherapy. 1: 61-74. PMID 15555468 DOI: 10.1016/S1543-5946(03)90002-X |
0.743 |
|
| 2003 |
Wrobel MV, Doshi J, Stuart BC, Briesacher B. Predictability of prescription drug expenditures for Medicare beneficiaries. Health Care Financing Review. 25: 37-46. PMID 15124376 |
0.493 |
|
| 2003 |
Kamal-Bahl SJ, Doshi JA, Stuart BC, Briesacher BA. Propoxyphene use by community-dwelling and institutionalized elderly Medicare beneficiaries. Journal of the American Geriatrics Society. 51: 1099-104. PMID 12890072 DOI: 10.1046/J.1532-5415.2003.51358.X |
0.713 |
|
| 2003 |
Kamal-Bahl S, Stuart B, Briesacher B, Doshi J. ASI: CHANGES IN FUNCTIONAL DISABILITY LEVELS AND MEDICAL EXPENDITURES AMONG ELDERLY PERSONS Value in Health. 6: 195. DOI: 10.1016/S1098-3015(10)63844-2 |
0.524 |
|
| 2003 |
Stuart B, Doshi J, Briesacher B, Wrobel M. PRP14 COST OFFSETS FROM PRESCRIPTION COVERAGE OF AGED PERSONS WITH COPD Value in Health. 6: 781. DOI: 10.1016/S1098-3015(10)61989-4 |
0.541 |
|
| 2002 |
Kamal-Bahl S, Doshi J, Campbell J. Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review. Archives of Pediatrics & Adolescent Medicine. 156: 1034-41. PMID 12361451 DOI: 10.1001/Archpedi.156.10.1034 |
0.632 |
|
| Show low-probability matches. |